引用本文:秦 诚,郭 婕,杨 焘,起俊军,张桥文,李垂金,潘秀镭,何国礼,刘立华.减臂机器人辅助下腹腔镜低位直肠癌根治术治疗男性低位直肠癌的临床效果观察[J].中国临床新医学,2026,19(7):835-840.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 249次   下载 9 本文二维码信息
码上扫一扫!
减臂机器人辅助下腹腔镜低位直肠癌根治术治疗男性低位直肠癌的临床效果观察
秦 诚,郭 婕,杨 焘,起俊军,张桥文,李垂金,潘秀镭,何国礼,刘立华
广西壮族自治区南溪山医院(广西壮族自治区第二人民医院)胃肠外科,桂林 541002
摘要:
[摘要] 目的 观察减臂机器人辅助下腹腔镜低位直肠癌根治术治疗男性低位直肠癌的临床效果。方法 回顾性分析2021年10月至2025年5月广西壮族自治区南溪山医院胃肠外科收治的186例男性低位直肠癌患者的临床资料,所有患者均顺利完成机器人辅助下腹腔镜低位直肠癌根治术(Dixon)+预防性回肠造口术。根据手术方式将其分为常规组(接受常规机器人辅助下腹腔镜低位直肠癌根治术,81例)和减臂组(接受减臂机器人辅助下腹腔镜低位直肠癌根治术,105例)。比较两组围术期指标、住院费用、并发症发生情况以及术后排便功能、排尿功能。结果 减臂组住院费用低于常规组,差异有统计学意义(P<0.05),两组手术时间、术中出血量、术后排气时间、淋巴结检出数以及术后住院时间比较差异无统计学意义(P>0.05)。两组术后并发症总发生率比较差异无统计学意义(P>0.05)。减臂组和常规组分别有93例和75例患者按计划返院行回肠造口还纳术并成功出院。两组国际前列腺症状量表(IPSS)评分、低位前切除综合征(LARS)评分结果比较差异无统计学意义(P>0.05)。结论 减臂机器人辅助下腹腔镜低位直肠癌根治术治疗男性低位直肠癌的效果与常规机器人手术相当,未增加不良事件发生风险,且更具经济优势,值得临床推荐。
关键词:  低位直肠癌  达芬奇机器人  减臂手术  男性
DOI:10.3969/j.issn.1674-3806.2026.07.10
分类号:R 657.1
基金项目:桂林市科学研究与技术开发计划项目(编号:20230135-6-4)
Observation on clinical outcomes of arm-reduced robot-assisted laparoscopic radical resection in males with low rectal cancer
Qin Cheng, Guo Jie, Yang Tao, Qi Junjun, Zhang Qiaowen, Li Chuijin, Pan Xiulei, He Guoli, Liu Lihua
Department of Gastrointestinal Surgery, Nanxishan Hospital of Guangxi Zhuang Autonomous Region(the Second People′s Hospital of Guangxi Zhuang Autonomous Region), Guilin 541002, China
Abstract:
[Abstract] Objective To observe clinical outcomes of arm-reduced robot-assisted laparoscopic radical resection in males with low rectal cancer. Methods The clinical data of 186 male patients with low rectal cancer who were admitted to the Department of Gastrointestinal Surgery of Nanxishan Hospital of Guangxi Zhuang Autonomous Region from October 2021 to May 2025 were retrospectively analyzed. The robot-assisted laparoscopic radical resection of low rectal cancer(Dixon) plus prophylactic ileostomy were successfully completed in all the patients. According to the surgical approaches, the patients were divided into the conventional group(receiving conventional robot-assisted laparoscopic radical resection of low rectal cancer, 81 patients) and the arm-reduced group(receiving arm-reduced robot-assisted laparoscopic radical resection of low rectal cancer, 105 patients). The perioperative indicators, hospitalization expenses, occurrence of complications, as well as postoperative defecation function and urination function were compared between the two groups. Results The hospitalization expenses of the arm-reduced group were lower than those of the conventional group, with statistically significant differences(P<0.05). There were no statistically significant differences in the operative duration, intraoperative blood loss, time to first flatus, number of harvested lymph nodes and length of postoperative hospital stay between the two groups(P>0.05). There was no statistically significant difference in the total incidence of postoperative complications between the two groups(P>0.05). A total of 93 patients in the arm-reduced group and 75 patients in the conventional group underwent scheduled ileostomy reversal and were successfully discharged from the hospital. There were no statistically significant differences in International Prostate Symptom Scale(IPSS) scores and low anterior resection syndrome(LARS) scores between the two groups(P>0.05). Conclusion The clinical outcomes of arm-reduced robot-assisted laparoscopic radical resection are comparable to those of conventional robot-assisted laparoscopic radical resection in treatment of low rectal cancer in male patients. The arm-reduced robot-assisted laparoscopic radical resection does not increase the risk of adverse events, and has more economic advantages, and therefore is worthy of clinical recommendation.
Key words:  low rectal cancer  da Vinci robot  arm reduction surgery  males